Literature DB >> 30376798

Effectiveness evaluation of radiosynovectomy on the radiological progression of osteoarthritis of the knee joint.

Imre Szerb1, Tamás Gál, László Hangody, Ibolya Mikó.   

Abstract

OBJECTIVES: This study aims to analyze the effect of radiosynovectomy (RSO) on the radiological progression of osteoarthritis of the knee joint. PATIENTS AND METHODS: The study included 207 knee joints of 181 patients (72 males, 109 females; mean age 58 years; range, 19 to 65 years) that were performed RSO between 01 April 2003 and 31 December 2015 in the Department of Orthopedics and Traumatology at Uzsoki Hospital. A total of 111 right and 96 left knees were treated. The mean duration of follow-up was 8.7 years (range, 1 to 12 years). Of the 181 patients, both knee joints were treated in 26.
RESULTS: Of the 207 treated knee joints, 163 had the same Kellgren-Lawrence grade at the time of follow-up compared to the grade at the time of RSO, while 44 had worse outcomes. This indicated that radiological progression was not present in 79% of the treated knee joints. The intraclass correlation coefficient (ICC) showed significantly strong agreement between the pre- and post-measurements (ICC=0.835, p<0.001).
CONCLUSION: Radiosynovectomy was able to impede radiological progression in 79% of the treated joints and only one-grade deterioration was observed in 39 cases during follow-up.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30376798     DOI: 10.5606/ehc.2018.61097

Source DB:  PubMed          Journal:  Eklem Hastalik Cerrahisi


  2 in total

1.  Cangxitongbi capsule protects articular cartilage of the knee in rats by regulating ADAMTS-5.

Authors:  Xu-Yu Song; Wen-Peng Xie; Peng Zhang; Min Zhao; Rong-Xiu Bi
Journal:  Ann Transl Med       Date:  2020-11

2.  The EANM guideline for radiosynoviorthesis.

Authors:  W U Kampen; B Boddenberg-Pätzold; M Fischer; M Gabriel; R Klett; M Konijnenberg; E Kresnik; H Lellouche; F Paycha; L Terslev; C Turkmen; F van der Zant; L Antunovic; E Panagiotidis; G Gnanasegaran; T Kuwert; T Van den Wyngaert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-20       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.